Abbott Structural Heart
Abbott Structural Heart is dedicated to providing innovative therapies and solutions for structural heart diseases, including stroke risk reduction, congenital defects, and valve diseases. They focus on advancing minimally invasive, transcatheter procedures to improve patient outcomes, reduce the need for open-heart surgery, and support healthcare providers with training and support. Their portfolio includes a broad range of products for conditions such as atrial septal defect (ASD), ventricular septal defect (VSD), patent ductus arteriosus (PDA), aortic stenosis, mitral regurgitation, and tricuspid regurgitation, serving patients from infants to the elderly.
Industries
Nr. of Employees
small (1-50)
Products
Transcatheter mitral and tricuspid edge-to-edge repair system
Catheter-delivered leaflet approximation system for percutaneous reduction of mitral or tricuspid regurgitation in patients at elevated surgical risk.
Transcatheter aortic valve implantation system
Catheter-delivered bioprosthetic valve and delivery system intended for transcatheter aortic valve implantation in patients at elevated surgical risk.
Surgical bioprosthetic and stented tissue valves
Stented tissue valves intended for surgical aortic and mitral valve replacement, designed to support lifetime management strategies.
Mechanical bileaflet heart valve prostheses
Mechanical valve prostheses incorporating bileaflet geometry and engineered pivot/hinge designs to optimize hemodynamics and durability.
Left atrial appendage occlusion device
Percutaneous occlusion device intended to reduce thromboembolic risk from the left atrial appendage in selected patients with atrial fibrillation.
Patent foramen ovale (PFO) closure device
Catheter-delivered occlusion system designed to close patent foramen ovale to reduce recurrent ischemic stroke risk in selected patients.
Transcatheter mitral and tricuspid edge-to-edge repair system
Catheter-delivered leaflet approximation system for percutaneous reduction of mitral or tricuspid regurgitation in patients at elevated surgical risk.
Transcatheter aortic valve implantation system
Catheter-delivered bioprosthetic valve and delivery system intended for transcatheter aortic valve implantation in patients at elevated surgical risk.
Surgical bioprosthetic and stented tissue valves
Stented tissue valves intended for surgical aortic and mitral valve replacement, designed to support lifetime management strategies.
Mechanical bileaflet heart valve prostheses
Mechanical valve prostheses incorporating bileaflet geometry and engineered pivot/hinge designs to optimize hemodynamics and durability.
Left atrial appendage occlusion device
Percutaneous occlusion device intended to reduce thromboembolic risk from the left atrial appendage in selected patients with atrial fibrillation.
Patent foramen ovale (PFO) closure device
Catheter-delivered occlusion system designed to close patent foramen ovale to reduce recurrent ischemic stroke risk in selected patients.
Services
Onsite and remote procedural training, imaging proctoring and case support for centers implementing structural heart procedures.
Collaboration with clinical investigators and institutions to design, run and support sponsored and investigator-led clinical studies and registries.
Educational resources and guidance for pre-procedural imaging screening, intra-procedural imaging techniques and multimodality imaging interpretation.
Provision of web and mobile applications, clinic locator tools and remote monitoring resources for clinicians and patients.
Channels for medical information requests, product advisories and reimbursement/coding guidance to support clinical adoption.
Design and dissemination support for pivotal and continued-access clinical studies and long-term follow-up data for devices intended for neonatal and pediatric use.
Onsite and remote procedural training, imaging proctoring and case support for centers implementing structural heart procedures.
Collaboration with clinical investigators and institutions to design, run and support sponsored and investigator-led clinical studies and registries.
Educational resources and guidance for pre-procedural imaging screening, intra-procedural imaging techniques and multimodality imaging interpretation.
Provision of web and mobile applications, clinic locator tools and remote monitoring resources for clinicians and patients.
Channels for medical information requests, product advisories and reimbursement/coding guidance to support clinical adoption.
Design and dissemination support for pivotal and continued-access clinical studies and long-term follow-up data for devices intended for neonatal and pediatric use.
Expertise Areas
- Clinical trial management and multicenter study operations
- Structural heart interventions (transcatheter and surgical)
- Transcatheter edge-to-edge repair (TEER) for mitral and tricuspid valves
- Transcatheter aortic valve replacement (TAVR/TAVI) systems
Key Technologies
- Transcatheter edge-to-edge leaflet repair (TEER)
- Transcatheter aortic valve implantation systems
- Occluder device systems for ASD/VSD/PDA/PFO/LAA
- Steerable catheter sheaths and delivery systems